SCHEMBL30258316

SCHEMBL30258316

Cn1nc(CC#N)c2ccc(Br)cc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSNK2A1 P68400 2/20 0.40
▸ PDE10A Q9Y233 2/20 0.36
▸ PDGFRA P16234 1/20 0.35
▸ CDK5 Q00535 1/20 0.35
▸ TYRO3 Q06418 1/20 0.35
▸ PDE5A O76074 1/20 0.33
▸ PDE4D Q08499 1/20 0.33
▸ ADORA2A P29274 1/20 0.33
▸ ADORA2B P29275 1/20 0.33
▸ PTGES O14684 1/20 0.32
▸ MAPK8 P45983 1/20 0.32
▸ CHEK1 O14757 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ BACE1 P56817 1/20 0.31
▸ ESR1 P03372 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ MAPT P10636 2/20 0.31
▸ LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26621602 1.00 CSNK2A1 (0.40) CSNK2A1PDE10APDGFRACDK5TYRO3
SCHEMBL4507507 0.81 GRM4 (0.43) PDGFRACDK5TYRO3ADORA2AADORA2B
SCHEMBL31068115 0.81 PDGFRA (0.39) PDGFRACDK5TYRO3ADORA2AADORA2B
SCHEMBL29349067 0.81 PDGFRA (0.39) PDGFRACDK5TYRO3ADORA2AADORA2B
SCHEMBL30258317 0.80 PDGFRA (0.41) PDGFRACDK5TYRO3ADORA2AADORA2B
SCHEMBL20520453 0.80 PDGFRA (0.41) PDGFRACDK5TYRO3ADORA2AADORA2B
SCHEMBL20520398 0.80 PDGFRA (0.38) PDGFRACDK5TYRO3ADORA2AADORA2B
SCHEMBL30258108 0.80 PDGFRA (0.38) PDGFRACDK5TYRO3ADORA2AADORA2B
SCHEMBL22122298 0.77 PDGFRA (0.44) CSNK2A1PDE10APDGFRACDK5TYRO3
SCHEMBL17673889 0.77 PDGFRA (0.39) PDGFRACDK5TYRO3ADORA2AADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4735452-A2 HETEROBIFUNCTIONAL COMPOUNDS FOR THE DEGRADATION OF KRAS PROTEIN Merck Patent GmbH (DE) 2026-05-06 — — EP disclosed
EP-4735438-A2 HETEROBIFUNCTIONAL COMPOUNDS FOR THE DEGRADATION OF KRAS Merck Patent GmbH (DE) 2026-05-06 — — EP disclosed
CN-119604493-A Heterocyclic compounds as BCL6 modulators useful as ligand-directed degradants 细胞基因公司 2025-03-11 — — CN disclosed
WO-2025006783-A2 HETEROBIFUNCTIONAL COMPOUNDS FOR THE DEGRADATION OF KRAS MERCK PATENT GMBH (DE) 2025-01-02 — — WO disclosed
WO-2025006753-A2 HETEROBIFUNCTIONAL COMPOUNDS FOR THE DEGRADATION OF KRAS PROTEIN MERCK PATENT GMBH (DE) 2025-01-02 — — WO disclosed
WO-2023059792-A1 CORONAVIRUS NON-STRUCTURAL PROTEIN 3 DEGRADING COMPOUNDS C4 THRAPEUTICS, INC. (US) 2023-04-13 — — WO disclosed
Send feedback